U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06859801) titled 'A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated with Percutaneous Ablation and Palliative Radiation Therapy' on Feb. 28.

Brief Summary: The objective of this study is to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in patients treated with both percutaneous ablation and palliative radiation therapy (RT).

Study Start Date: July 01, 2025

Study Type: OBSERVATIONAL

Condition: Bone Cancer Metastatic

Intervention: DEVICE: Percutaneous Ablation

Percutaneous ablation is a minimally invasive alternative therapy for metas...